Jubilant Life Sciences
Rakesh Jhunjhunwala Stocks: HUGE impact! Jubilant Ingrevia share price rises over 20 pct after Big Bull hikes stake
Tue, Mar 23, 2021
Rakesh Jhunjhunwala Portfolio Stocks: After the news broke about ace Indian stock market investor Rakesh Jhunjhunwala purchasing 3.04 lakh more shares of Jubilant Ingrevia thereby increasing his shareholding to 6.23 per cent, the company's shares have skyrocketed.
More >
Coronavirus Vaccine: Jubilant Life Sciences launches remdesivir for injection
Tue, Aug 04, 2020
Coronavirus Vaccine: Jubilant Life Sciences Ltd on Monday announced that its subsidiary, Jubilant Generics, has launched remdesivir for injection, under the brand name `JUBI-R`, in the Indian market at a price of Rs 4,700 per vial of 100 mg.
More >
Stocks in Focus on August 4: Spencer’s Retail, Exide Industries to Jubilant Life Sciences; here are expected newsmakers of the day
Tue, Aug 04, 2020
Stocks in Focus on August 4: Spencer’s Retail, Exide Industries, Jubilant Life Sciences, BSE, Dhanlaxmi Bank, etc. are expected newsmakers throughout the intraday trade session.
More >
Covid 19 medicine in India: Gilead Sciences ties up with Noida-based Jubilant to sell remdesivir
Wed, May 13, 2020
Covid 19 medicine in India: Noida-based Jubilant Life Sciences on Tuesday announced that its subsidiary Jubilant Generics Ltd has entered into a non-exclusive licensing agreement with US-based Gilead Sciences to manufacture and sell anti-viral drug remdesivir, which is under clinical trials globally as a potential treatment of COVID-19 disease
More >
Four stocks where Rakesh Jhunjhunwala holds half his wealth; did you invest in them? They are multibaggers going forward
Mon, Dec 10, 2018
Just like every other stock, Jhunjhunwala’s portfolio also could not do the impossible and rise. However, as time turns around all that Jhunjhunwala needed is his favorite stock to shine to retain gains this year.
More >
Like it or not, Rakesh Jhunjhunwala set to earn big! This midcap seen making him richer with 73% gains; should you buy?
Mon, Dec 03, 2018
Guess what! This stock is also under Jhunjhunwala's ambit, in fact the investor has recently increased his holding in that company! If you also own this stock just like Jhunjhunwala, then you will see return of nearly 73%.
More >
